Skip to search formSkip to main contentSkip to account menu

Daunorubicin citrate

Known as: 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 
A semi-synthetic anthracycline glycoside antibiotic obtained from Streptomyces with antineoplastic activity. Daunorubicin citrate intercalates DNA… 
National Institutes of Health

Related topics

Related topics

1 relation
Daunorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals.
Kaposi's Sarcoma (KS) is a multicentric angioproliferative cancer of endothelial cells (ECs) caused by Human Herpesvirus 8 (HHV8… 
Review
2004
Review
2004
Advantages of liposomal delivery systems for anthracyclines.
Liposomes, closed vesicular structures consisting of one or more lipid bilayers, have generated a great deal of interest as drug… 
Review
2004
Review
2004
Use of liposomal anthracyclines in Kaposi's sarcoma.
Conventional chemotherapy regimens for the treatment of advanced Kaposi's sarcoma (KS) show limited efficacy and considerable… 
1998
1998
Health care personnel alerted to problems with lipid-based products, albumin.
Health care personnel alerted to problems with lipid-based products, albumin about dilution of concentrated albumin. Because of a… 
1996
1996
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
The Food and Drug Administration (FDA) approved NeXstar Pharmaceuticals' anticancer drug DaunoXome (daunorubicin citrate… 
1996
1996
NeXstar Pharmaceuticals lauches DaunoXome.
NeXstar Pharmaceuticals has begun marketing DaunoXome (daunorubicin citrate liposome injection), which maximizes the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)